March 23, 2018 / 7:17 AM / a month ago

BRIEF-Indivior Says ‍U.S. Court Found Alvogen Does Not Infringe Claims Of Certain U.S. Patent​s

March 23 (Reuters) - Indivior Plc:

* INDIVIOR RESPONDS TO COURT RULING ANDA LITIGATION

* ‍RESPONDS TO COURT RULING IN ANDA LITIGATION AND ANNOUNCES INTENTION TO APPEAL

* INDIVIOR - ‍US DISTRICT COURT FOR DISTRICT OF DELAWARE HAS FOUND THAT ALVOGEN DOES NOT INFRINGE ASSERTED CLAIMS OF CERTAIN U.S. PATENT​S

* INDIVIOR PLC - ‍BELIEVES THAT IT HAS GROUNDS TO APPEAL RULING BY DISTRICT COURT OF DELAWARE​

* INDIVIOR - WILL NOT BE ABLE TO RELY ON ‘514, ‘150, AND ‘497 PATENTS TO PREVENT ALVOGEN FROM MANUFACTURING AND MARKETING A GENERIC FILM ALTERNATIVE IN US​​

* ‍FINANCIAL GUIDANCE FOR FY 2018, PROVIDED BY INDIVIOR ON FEBRUARY 15, 2018, IN ITS FY 2017 RESULTS, ASSUMED NO GENERIC FILM LAUNCH IN 2018​

* ‍COMPANY WILL CONTINUE TO MONITOR MARKET CONDITIONS AND WILL UPDATE ITS FINANCIAL GUIDANCE IF APPROPRIATE.

* INDIVIOR - WILL NOT BE ABLE TO RELY ON ‘514, ‘150, AND ‘497 PATENTS TO PREVENT ALVOGEN FROM MANUFACTURING AND MARKETING A GENERIC FILM ALTERNATIVE IN US​

* INDIVIOR PLC - ‍IF FDA GRANTS APPROVAL TO ALVOGEN, IT WOULD BE ABLE TO MARKET A GENERIC ALTERNATIVE TO SUBOXONE® FILM IN US​

* INDIVIOR - ‍EXPECT TO EXTEND MARKET LEADING POSITION IN ADDICTION DISEASE SPACE, REMAIN CONFIDENT IN ACHIEVING AT LEAST $1 BLN IN PEAK SUBLOCADE NET REVENUE​​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below